By preventing ACSL4 activity, triacsin C can alleviate parkinson’s disease (PD); and clausenamide can also alleviate behavioural impairments in PD animal models by preventing the nuclear translocation of ALOX5. This evidence concerns the gene ALOX5 and Parkinson disease.